2 research outputs found

    The Effects of Partial Body Weight Support for Gait for Patients with Neurological Dysfunction: A Case Study Approach

    Get PDF
    The purpose of this study was to determine the effects of partial body weight support during gait for individuals with neurological dysfunction. Body weight support (BWS) training provides a safe environment in which the individual can perform and practice mechanics of normal gait at a variety of speeds with or without body weight support, depending on the level of function. The subjects who participated in this study were community ambulators older than 20 years of age with a neurological diagnosis. Each subject was tested initially and at the conclusion of the study to compare data using a battery of balance and gait tests. Each subject participated in body weight support treadmill gait training using the LiteGaitTM three times a week for up to six weeks. Each subject was to begin with 40% body weight support (BWS) and a treadmill speed of .5 mph, progress to 20% BWS and a speed of .7 mph, and finally to 0% BWS and a speed of 1.0 mph. All three subjects made improvements when comparing initial to final testing results. Many factors may have limited the results of our study including the tester, sensitivity of the tests performed, or sudden changes in medical status

    Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson’s Disease Utilizing LSVT BIG®

    No full text
    Individuals with Parkinson’s Disease (PD) are often not referred to Physical Therapy (PT) until there are issues with mobility in later Hoehn and Yahr Stages. There have been no studies outlining the benefits of PT intervention in Stage I only. For persons with PD, deficits in motor function increase over time due to destruction of dopamine-producing cells. LSVT BIG, an exercise program for PD, has been shown to be effective in improving mobility. The purpose of this study was to assess participants functional improvement at a level of minimal clinically important difference (MCID) in one of four outcome measures: Gait Speed, Berg Balance Assessment, Functional Gait Assessment, and Unified Parkinson’s Disease Rating Scale Motor Section. Case Description. Nine participants with Stage I PD received LSVT BIG 4x/week for 4 weeks followed by bimonthly participation in a community class. Outcome measurement occurred at baseline, after LSVT BIG, and three months after LSVT BIG. Outcomes. Eight of nine participants (88.9%) achieved MCID in at least one of the four measures at both after and 3 months after LSVT BIG training indicating improvement based on our criteria. Participants in Stage I of PD in this study completed LSVT BIG and demonstrated improved function
    corecore